Delivery Order SPE2DB22D2211-SPE2DB25FSFEC
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,635.56 firm fixed-price delivery order on August 29, 2025, for Dextroamphetamine ER 15 mg capsules (90-count units), with completion targeted for September 2, 2025. This non-set-aside award was issued to the vendor's Corporate Office located in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,905.89 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Dextroamphetamine ER 10 mg capsules (100 count). The award was competitively procured with no set-aside designation and requires ultimate completion by July 15, 2025. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,468.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dextroamphetamine ER 15 mg capsules (90-count supply) on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Dextroamphetamine ER 10 mg capsules (90-count) valued at $2,804.48. This competitively awarded, firm fixed-price delivery order was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at the vendor's corporate office location in Conshohocken, PA. The contract carries no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Dextroamphetamine ER 15 mg capsules (90-count units) with a ceiling value of $4,078.51. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count units) with a ceiling value of $5,827.15. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location, and is due for completion by September 11, 2025. The award represents a competitively awarded transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Dextroamphetamine ER 15 mg capsules (90-count units) with a contract value of $2,488.52. This firm fixed-price delivery order represents a non-set-aside competitive award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 3, 2025. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $1,386.27 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dextroamphetamine-Amphetamine 20 mg capsules (100 count) on August 6, 2025, with completion scheduled for August 7, 2025. This non-competitive, non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,695.44 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count) on September 12, 2025, with completion expected by September 15, 2025. This firm fixed-price delivery order carries no set-aside designation and was awarded competitively. The pharmaceutical will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a $14,269.44 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count). This is a firm fixed price, non-set-aside contract with a completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFECDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dextroamphetamine ER 15 mg capsules (100 count) with a ceiling value of $1,433.20. This firm fixed-price delivery order, awarded on September 17, 2025, represents a non-set-aside competitive award and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical supply requirements through open competition, including specialty medications, generic and brand-name drugs, vaccines, and specialized medical supplies. This specific delivery order for stimulant medication reflects the company's role in supporting military medical supply chain operations across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/17/25 |